LH Action in Ovarian Cell Differentiation
LH 在卵巢细胞分化中的作用
基本信息
- 批准号:8106817
- 负责人:
- 金额:$ 9.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AREG geneAromataseBiological ProcessCD14 geneCattleCell Differentiation processCell physiologyCellsComplement 1qComplexDataDevelopmentEGF geneEREG geneEmbryoEndocrineEpidermal Growth Factor ReceptorEventExhibitsExtracellular MatrixFertilityFertilizationFollicle Stimulating HormoneGene ExpressionGene TargetingGenerationsGenesGenetic ProgrammingGonadotropinsHumanHyaluronanImmuneInfertilityInflammationInflammatoryInflammatory ResponseInterleukin-6Knockout MiceLigandsLuteinizing HormoneMAPK1 geneMAPK3 geneMammalian OviductsMediatingMediator of activation proteinMenstrual cycleMolecularMolecular ProfilingMusMutant Strains MiceOocytesOvarianOvarian FollicleOvaryOvulationPathway interactionsProcessProductionProstaglandinsReactionRoleSignal TransductionSignaling MoleculeSurfaceSystemTLR2 geneTLR4 geneTestingToll-like receptorsWomanbasecytokinedesigngranulosa cellin vivoin vivo Modelmouse modelmutant mouse modelnoveloocyte maturationpromoterpublic health relevancereceptorresponse
项目摘要
DESCRIPTION (provided by applicant): Ovulation is the unique biological process by which a mature oocyte and surrounding cumulus cells, comprising the cumulus cell-oocyte complex (COC), are released from the surface of the ovary. This LH-induced process is similar to an inflammatory response and requires the expression of specific genes: the EGF-like factors (Areg, Ereg, Btc), matrix factors (Has2, Ptgs2, Tnfaip6, Ptx3) and cytokines (Il6). AREG potently activates ERK1/2, COC expansion, oocyte maturation and IL6 production in cultured COCs. However, the genes regulated specifically by AREG/ERK1/2 and the consequences of disrupting these signaling molecules in vivo have not been determined. Therefore, using Erk1 (Erk1-/-) null mice, Erk2fl/fl mice and mice expressing Cre driven by the aromatase (Cyp19) promoter, we have generated Erk1/2 double KO (Erk1-/- ;Erk2fl/fl/;Cyp19-Cre) mice. Follicular development is normal but preovulatory follicles fail to ovulate and COC expansion is impaired in the Erk1/2 double KO mice. In addition to inflammation-related genes, LH/AREG also regulate the expression of specific genes that comprise the innate-immune cell surveillance response system, including the Toll-like receptors TLR2 and TLR4 and components of this system (C1q, Cd14, and Pdcd1) uniquely expressed in cumulus cells. TLR2 and TLR4 are functional in cumulus cells and respond to known ligands (including matrix factors) leading to the production of IL6 that can induce COC expansion in culture in the absence of AREG or PGE. Preliminary data indicate that Tlr4-/- mice are subfertile. By analyzing the signaling cascades and the expression of specific genes in Erk1/2 double KO mice and in mice null for the Areg target genes (Tlr/42, Ptx3 and Pdcd1) that are expressed in COCs, we should be able to dissect and delineate a novel genetic program that controls cumulus cell function and ovulation. Because the production of cytokines, including IL6, appears to be critical for ovulation, we propose that the ERK1/2 pathway controls an endocrine-immune-cytokine regulatory network during ovulation. Therefore we propose these specific aims: Specific Aim I: Determine the molecular mechanisms by of ERK2 (MAPK1) and ERK1 (MAPK3) regulate granulosa cell and cumulus cell functions and ovulation in vivo. Test the hypothesis that ERK1/2 mediate specific effects of LH induced ovulation and cumulus cell function. Specific Aim II: Determine the function of AREG (ERK1/2) target genes that are uniquely expressed at high levels in ovulated COCs and that impact ovulation. Test the hypotheses that specific matrix factors, IL6 and innate immune cell-related genes expressed in cumulus cells direct the unique fate of these cells. PUBLIC HEALTH RELEVANCE: The studies being proposed in this application are designed to uncover new information about how ovarian follicles mature and ovulate in response to the gonadotropins, follicle stimulating hormone (FSH) and luteinizing hormone (LH). This information should help us understand the basis for infertility in women who have abnormal menstrual cycles, reduced ovarian function and are anovulatory.
描述(由申请人提供):排卵是一种独特的生物学过程,通过该过程,成熟卵母细胞和周围的卵丘细胞(包括卵丘细胞-卵母细胞复合体(COC))从卵巢表面释放。LH诱导的过程类似于炎症反应,需要特定基因的表达:EGF样因子(Areg,Ereg,Btc),基质因子(Has 2,Ptgs 2,Tnfaip 6,Ptx 3)和细胞因子(I16)。AREG有效激活培养的COCs中的ERK 1/2、COC扩增、卵母细胞成熟和IL 6产生。然而,由AREG/ERK 1/2特异性调节的基因以及在体内破坏这些信号分子的后果尚未确定。因此,使用Erk 1(Erk 1-/-)缺失小鼠、Erk 2fl/fl小鼠和表达由芳香酶(Cyp 19)启动子驱动的Cre的小鼠,我们已经产生了Erk 1/2双KO(Erk 1-/- ; Erk 2fl/fl/; Cyp 19-Cre)小鼠。在Erk 1/2双基因敲除小鼠中,卵泡发育正常,但排卵前卵泡不能排卵,COC扩增受损。除了炎症相关基因外,LH/AREG还调节组成先天免疫细胞监视反应系统的特定基因的表达,包括Toll样受体TLR 2和TLR 4以及在卵丘细胞中独特表达的该系统的组分(C1 q,Cd 14和Pdcd 1)。TLR 2和TLR 4在卵丘细胞中是功能性的,并且响应于已知的配体(包括基质因子),导致产生IL 6,其可以在不存在AREG或PGE的培养物中诱导COC扩增。初步数据表明Tlr 4-/-小鼠生育能力低下。通过分析Erk 1/2双基因敲除小鼠和COCs中表达的Areg靶基因(Tlr/42,Ptx 3和Pdcd 1)缺失小鼠中的信号级联和特定基因的表达,我们应该能够剖析和描述一种控制卵丘细胞功能和排卵的新遗传程序。由于细胞因子的产生,包括IL 6,似乎是排卵的关键,我们建议,ERK 1/2途径控制排卵期间的内分泌免疫细胞因子调节网络。因此,我们提出了这些具体的目标:具体目标一:确定ERK 2(MAPK 1)和ERK 1(MAPK 3)调节颗粒细胞和卵丘细胞功能和排卵的分子机制。检验ERK 1/2介导LH诱导排卵和卵丘细胞功能的特定作用的假设。具体目标二:确定AREG(ERK 1/2)靶基因的功能,这些靶基因在排卵的COCs中以高水平表达并影响排卵。测试特定的基质因子,IL 6和卵丘细胞中表达的先天免疫细胞相关基因指导这些细胞的独特命运的假设。公共卫生相关性:本申请中提出的研究旨在揭示关于卵泡如何响应促性腺激素、促卵泡激素(FSH)和促黄体激素(LH)而成熟和排卵的新信息。这些信息有助于我们了解月经周期异常、卵巢功能减退和无排卵妇女不孕的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JoAnne Stewart Richards其他文献
JoAnne Stewart Richards的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JoAnne Stewart Richards', 18)}}的其他基金
Novel Aspect of Androgen Action in Ovarian Cell Function and Dysfunction
雄激素在卵巢细胞功能和功能障碍中作用的新方面
- 批准号:
10172961 - 财政年份:2019
- 资助金额:
$ 9.39万 - 项目类别:
Novel Aspect of Androgen Action in Ovarian Cell Function and Dysfunction
雄激素在卵巢细胞功能和功能障碍中作用的新方面
- 批准号:
10415947 - 财政年份:2019
- 资助金额:
$ 9.39万 - 项目类别:
Novel Aspect of Androgen Action in Ovarian Cell Function and Dysfunction
雄激素在卵巢细胞功能和功能障碍中作用的新方面
- 批准号:
10640129 - 财政年份:2019
- 资助金额:
$ 9.39万 - 项目类别:
Novel Aspect of Androgen Action in Ovarian Cell Function and Dysfunction
雄激素在卵巢细胞功能和功能障碍中作用的新方面
- 批准号:
10006016 - 财政年份:2019
- 资助金额:
$ 9.39万 - 项目类别:
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
类固醇激素调节卵巢癌的进展和转移
- 批准号:
8923209 - 财政年份:2014
- 资助金额:
$ 9.39万 - 项目类别:
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
类固醇激素调节卵巢癌的进展和转移
- 批准号:
9538594 - 财政年份:2014
- 资助金额:
$ 9.39万 - 项目类别:
Mechanisms Controlling Divergent Fates of Ovarian Follicles and Fertility
控制卵巢卵泡和生育力不同命运的机制
- 批准号:
8694652 - 财政年份:2014
- 资助金额:
$ 9.39万 - 项目类别:
Mechanisms Controlling Divergent Fates of Ovarian Follicles and Fertility
控制卵巢卵泡和生育力不同命运的机制
- 批准号:
9273274 - 财政年份:2014
- 资助金额:
$ 9.39万 - 项目类别:
Mechanisms Controlling Divergent Fates of Ovarian Follicles and Fertility
控制卵巢卵泡和生育力不同命运的机制
- 批准号:
9527155 - 财政年份:2014
- 资助金额:
$ 9.39万 - 项目类别:
Mechanisms Controlling Divergent Fates of Ovarian Follicles and Fertility
控制卵巢卵泡和生育力不同命运的机制
- 批准号:
9070506 - 财政年份:2014
- 资助金额:
$ 9.39万 - 项目类别:
相似国自然基金
运动对骨骼肌 Aromatase/17β-estradiol 通路的影响及功能研究
- 批准号:19ZR1452900
- 批准年份:2019
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms
靶向 1-磷酸鞘氨醇 (S1P1) 受体治疗芳香酶抑制剂引起的肌肉骨骼症状
- 批准号:
10668781 - 财政年份:2023
- 资助金额:
$ 9.39万 - 项目类别:
Post-translational regulation of aromatase in aging
衰老过程中芳香酶的翻译后调控
- 批准号:
10976001 - 财政年份:2023
- 资助金额:
$ 9.39万 - 项目类别:
Post-translational regulation of aromatase in aging
衰老过程中芳香酶的翻译后调控
- 批准号:
10572625 - 财政年份:2023
- 资助金额:
$ 9.39万 - 项目类别:
Neuroanatomical substrates underpinning brain aromatase control of feeding behavior and metabolic homeostasis
支持大脑芳香酶控制摄食行为和代谢稳态的神经解剖学基质
- 批准号:
10737130 - 财政年份:2023
- 资助金额:
$ 9.39万 - 项目类别:
Comprehensive multi-omic analyses of "islands of resistance" tumour cells to identify aromatase inhibitor resistant subclones in ER+ breast cancer
对“耐药岛”肿瘤细胞进行全面的多组学分析,以鉴定 ER 乳腺癌中芳香酶抑制剂耐药的亚克隆
- 批准号:
2893229 - 财政年份:2023
- 资助金额:
$ 9.39万 - 项目类别:
Studentship
Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial
基于网络的疼痛应对技能培训,以改善乳腺癌幸存者芳香酶抑制剂相关关节痛引起的疼痛和依从性差(SKIP-关节痛):一项随机对照试验
- 批准号:
10439192 - 财政年份:2022
- 资助金额:
$ 9.39万 - 项目类别:
Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial
基于网络的疼痛应对技能培训,以改善乳腺癌幸存者芳香酶抑制剂相关关节痛引起的疼痛和依从性差(SKIP-关节痛):一项随机对照试验
- 批准号:
10630101 - 财政年份:2022
- 资助金额:
$ 9.39万 - 项目类别:
A reciprocal relationship between alcohol and the p450 enzyme aromatase
酒精和 p450 芳香酶之间的相互关系
- 批准号:
10681419 - 财政年份:2021
- 资助金额:
$ 9.39万 - 项目类别:
Inflammatory oxylipins and aromatase inhibitor toxicity in breast cancer
乳腺癌中的炎性氧脂素和芳香酶抑制剂毒性
- 批准号:
10178172 - 财政年份:2021
- 资助金额:
$ 9.39万 - 项目类别:
A reciprocal relationship between alcohol and the p450 enzyme aromatase
酒精和 p450 芳香酶之间的相互关系
- 批准号:
10386167 - 财政年份:2021
- 资助金额:
$ 9.39万 - 项目类别: